IBIO Financials

Income Statement
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026
Revenue
1.1M
0
0
0
-100.0%
100.0K
Cost of Revenue
0
0
0
0
0
Gross Profit
1.1M
0
0
0
-100.0%
100.0K
Operating Expenses
9.4M
-17.3%
11.4M
+36.0%
8.4M
0
-100.0%
6.1M
R&D
6.7M
-22.3%
8.6M
+163.0%
3.3M
0
-100.0%
3.5M
SG&A
2.8M
+226.6%
-2182000
-142.7%
5.1M
0
-100.0%
2.5M
Operating Income
-8338000
+26.7%
-11380000
-36.0%
-8365000
0
+100.0%
-5951000
EBITDA
-8188000
-31.5%
-6225000
+24.2%
-8213000
0
+100.0%
-5823000
Net Income
-7551000
+28.6%
-10580000
-36.3%
-7761000
0
+100.0%
-5720000
EPS (Basic)
$-0.05
-25.0%
$-0.04
+33.3%
$-0.06
$0.00
+100.0%
$-0.11
EPS (Diluted)
$-0.05
-25.0%
$-0.04
+33.3%
$-0.06
$0.00
+100.0%
$-0.11
Shares (Diluted)
151.6M
-37.8%
243.7M
+103.7%
119.6M
0
-100.0%
53.0M
iBio (IBIO) — Financials